Skip to content

Comparison of Intraoperative lung protective ventilation with conventional ventilation on postoperative pulmonary complications in CABG

Evaluation of Intraoperative lung protective ventilation with conventional ventilation on postoperative pulmonary complications in CABG

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015040115774N3
Enrollment
64
Registered
2015-06-25
Start date
2014-03-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperation complications of respiratory system. Postprocedural respiratory disorder, unspecified

Interventions

Intervention 1: The control group receives common ventilation with tidal volume= 9 ml/kg and respiratory rate adjustment with EtCO2= 30-35 cmH20 and PEEP=0. Intervention 2: Intervention group recieves
Treatment - Devices
The control group receives common ventilation with tidal volume= 9 ml/kg and respiratory rate adjustment with EtCO2= 30-35 cmH20 and PEEP=0.
Intervention group recieves lung protective ventilation with tidal volume=6 ml/kg and respiratory rate adjustment with EtCo2=30-35 cmH2o and PEEP=10 cmH2o. In the intervention group, the recruitment m

Sponsors

Vice chancellor for research, Iran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are patients candidate for CABG operation under general anesthesia; Patient's satisfaction with participating in the study and doing the respiratory examinations; BMI< 30 kg/m² age more than 18 and under 70; No pregnancy; No emergent surgery; No previous respiratory system surgery; No history of chronic obstructive pulmonary disease; No sleep disorder; No History of immune suppressant therapy( chemotherapy or radiotherapy) in the last 2 months; No acute respiratory damage or acute respiratory distress syndrome; No repeated treatment with systemic corticosteroid; No liver or neuromuscular disorders; No alcohol or substance abuse; No anesthetic drugs allergy; No cigarette smoking (less than 10 pack/year). Exclusion criteria are Hemoglobin < 10; Albumin <3 g/dl; Continuous hemodynamic unstability; Resistant shock; Prediction of long term mechanical ventilation after the surgery; non-early extubation (more than 6 hours after end of the surgery).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications. Timepoint: after the surgery. Method of measurement: 3 or more of these six postoperative pulmonary complications: cough, discharge increase, dyspnea, chest pain, temperature more than 38C, heart rate >100 per minute.

Secondary

MeasureTime frame
Modified Clinical Pulmonary Infection Score. Timepoint: After the surgery. Method of measurement: According to mentioned parameteres : Glasco scale, Mean Arterial Pressure, need for vasopressor to support cardiovascular system,Serum Aspartate Transaminase Level, Liver bilirubin, Protrombin time and platlets, coagulation factors and serum creatine.;IL-6 levels. Timepoint: before, exactly after and also after 24 hours of the surgery. Method of measurement: laboratory.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026